RecruitingNCT00344188
16
studies recruiting now
as of 7 Sept 2026
213
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
24 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07783243
Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis
RecruitingNot applicableNCT06746350
Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
RecruitingPhase 3NCT06822478
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
RecruitingNCT07504757
LEISH-PED: Study on Leishmaniasis in Children
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 16 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Leishmaniasis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Leishmaniasis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
12 approved treatments and 14 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Nitrofurazone (Actin-n)Approved: Nifurtimox (Lampit)Approved: Acetarsone (Gynoplix)Approved: BenznidazoleApproved: Sodium Stibogluconate (Pentostam)Approved: FexinidazoleApproved: EflornithineApproved: Meglumine AntimonateApproved: Pentamidine Isethionate (Nebupent)Approved: Suramin HexasodiumApproved: Miltefosine (Impavido)Approved: Melarsoprol (Mel b)
Phase 3Amphotericin B (Abelcet)
Phase 3Voriconazole (Vfend)
Phase 3Doxycycline (Doxirobe)
Phase 3Paromomycin Sulfate (Aminosidine)
Phase 2Meglumine
Phase 2Sitamaquine
Phase 2Gentamicin
Phase 2Pentamidine (Pentacarinat)
+ 6 more in development
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).